Abhishek Sharma
I’m Abhishek Sharma, an Advocate based in Delhi, entrepreneur, investor, and founder of BigBreakingWire. I am an enrolled Advocate with a strong interest in entrepreneurship, media, and technology. I founded BigBreakingWire, a digital news platform covering breaking news, business, financial markets, companies, and important developments in India and around the world. I also have a software company and take an active interest in technology, software, AI, digital products, and new business ideas. As an investor, I’m interested in discovering and investing in promising businesses and startups. I look for good ideas, strong founders, practical business models, and opportunities with long-term potential. I enjoy building businesses, learning about new industries, and connecting with people who are working on interesting ideas and opportunities. Advocate | Entrepreneur | Investor | Founder & Editor-in-Chief, BigBreakingWire
Articles by Abhishek Sharma
𝐓𝐚𝐭𝐚 𝐌𝐨𝐭𝐨𝐫𝐬 Sold 9.9% Stake in 𝐓𝐚𝐭𝐚 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬
🚨 UBS Chairman: No doubt there’s an asset bubble in private credit
Tata Power Forecasts a 600 Billion Rupee Capital Expenditure Journey Through FY27
Honasa Consumer Denies Block Deal of ESOPs Amidst Market Speculation
Hedge funds sold a largest volume of U.S. tech and media stocks in the week ending Nov. 24.: Goldman Sachs
Hon Hai Precision Industry to Invest $1.6 Billion in Indian Manufacturing Expansion
Mamaearth’s Honasa Employees Set to Sell Rs 150 Crore ESOPs in Block Deal
India’s Grand Wedding Extravaganza: A $51 Billion Economic Boost
Tesla Eyes $2 Billion Investment for Indian Factory Amid Import Duty Talks
Coca-Cola’s Honest Tea: Brewing Success in India’s Evolving Beverage Landscape
RBI Governor Shaktikanta Das Stresses Dual Focus on Inflation and Growth in Comprehensive Economic Address
Bezos to sell 8-10 Million Amazon Shares
France and US Propose Ban on Private Financing for Coal-Fired Plants at COP28
India’s Electric Vehicle Revolution: Equal Incentives for Local and Foreign Players
India’s Ambitious Vision: A $200 Billion Pharmaceutical Industry by 2030